Genomic biomarkers of SUDEP in brain and heart

Epilepsy and Behavior

Volumn 38, Issue , 2014, Pages 172-179

  Glasscock, Edward ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Brain heart connection; Cardiac arrhythmia; Dravet syndrome; Epilepsy; Gene profile; Genomic biomarker; Long QT syndrome; Personalized medicine; SUDEP

Indexed keywords

BIOLOGICAL MARKER; CYCLIC NUCLEOTIDE GATED CHANNEL; HCN2 CHANNEL; KCNH2 CHANNEL; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KV1.1; RYANODINE RECEPTOR 2; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; UNCLASSIFIED DRUG;

BRAIN DEATH; CORRELATIONAL STUDY; EPILEPSY; GENOTYPE; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; LONGEVITY; NONHUMAN; PHENOTYPE; QUALITY OF LIFE; REVIEW; SUDDEN CARDIAC DEATH; ANIMAL; GENETICS; HEART DISEASE; SUDDEN DEATH;

ANIMALS; BIOMARKERS; DEATH, SUDDEN; EPILEPSY; HEART DISEASES; HUMANS;

EID: 84910598223     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.09.019     Document Type: Review

References (150)

1. Couzin J. Epilepsy. When death strikes without warning. Science 2008, 321:31-33.
2. Ficker D.M., So E.L., Shen W.K., Annegers J.F., O'Brien P.C., Cascino G.D., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 1998, 51:1270-1274.
3. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012, 53:227-233.
4. Hughes J.R. A review of sudden unexpected death in epilepsy: prediction of patients at risk. Epilepsy Behav 2009, 14:280-287.
5. Blum A.S. Respiratory physiology of seizures. J Clin Neurophysiol 2009, 26:309-315.
6. Leung H., Kwan P., Elger C.E. Finding the missing link between ictal bradyarrhythmia, ictal asystole, and sudden unexpected death in epilepsy. Epilepsy Behav 2006, 9:19-30.
7. Richerson G.B., Buchanan G.F. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia 2011, 52(Suppl. 1):28-38.
8. Bardai A., Lamberts R.J., Blom M.T., Spanjaart A.M., Berdowski J., van der Staal S.R., et al. Epilepsy is a risk factor for sudden cardiac arrest in the general population. PLoS One 2012, 7:e42749.
9. Nashef L., Hindocha N., Makoff A. Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 2007, 48:859-871.
10. Monté C.P.J.A., Arends J.B.A.M., Tan I.Y., Aldenkamp A.P., Limburg M., de Krom M.C.T.F.M. Sudden unexpected death in epilepsy patients: risk factors. A systematic review. Seizure 2007, 16:1-7.
11. Lamberts R.J., Thijs R.D., Laffan A., Langan Y., Sander J.W. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 2012, 53:253-257.
12. Jehi L., Najm I.M. Sudden unexpected death in epilepsy: impact, mechanisms, and prevention. Cleve Clin J Med 2008, 75(Suppl. 2):S66-S70.
13. Atkinson A., Colburn W., DeGruttola V., DeMets D., Downing G., Hoth D., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
14. Kelley M.S., Jacobs M.P., Lowenstein D.H. The NINDS epilepsy research benchmarks. Epilepsia 2009, 50:579-582.
15. Simon R. Genomic biomarkers in predictive medicine: an interim analysis. EMBO Mol Med 2011, 3:429-435.
16. Novelli G., Ciccacci C., Borgiani P., Papaluca Amati M., Abadie E. Genetic tests and genomic biomarkers: regulation, qualification and validation. Clin Cases Miner Bone Metab 2008, 5:149-154.
17. Klassen T., Davis C., Goldman A., Burgess D., Chen T., Wheeler D., et al. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 2011, 145:1036-1048.
18. Steffens M., Leu C., Ruppert A.-K., Zara F., Striano P., Robbiano A., et al. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet 2012, 21:5359-5372.
19. Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C., Steiner I., et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012, 53:1387-1398.
20. + channels in terminal and juxtaparanodal regions of neurons. Nature 1993, 365:75-79.
21. Tempel B.L., Jan Y.N., Jan L.Y. Cloning of a probable potassium channel gene from mouse brain. Nature 1988, 332:837-839.
22. Coleman S.K., Newcombe J., Pryke J., Dolly J.O. Subunit composition of Kv1 channels in human CNS. J Neurochem 1999, 73:849-858.
23. Kamb A., Iverson L.E., Tanouye M.A. Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell 1987, 50:405-413.
24. Wang H., Kunkel D.D., Schwartzkroin P.A., Tempel B.L. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J Neurosci 1994, 14:4588-4599.
25. Jan L.Y., Jan Y.N. Voltage-gated potassium channels and the diversity of electrical signalling. J Physiol (Lond) 2012, 590:2591-2599.
26. Glasscock E., Qian J., Kole M.J., Noebels J.L. Transcompartmental reversal of single fibre hyperexcitability in juxtaparanodal Kv1.1-deficient vagus nerve axons by activation of nodal KCNQ channels. J Physiol (Lond) 2012, 590:3913-3926.
27. Glasscock E., Yoo J.W., Chen T.T., Klassen T.L., Noebels J.L. Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J Neurosci 2010, 30:5167-5175.
28. Harrell M.D., Harbi S., Hoffman J.F., Zavadil J., Coetzee W.A. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiol Genomics 2007, 28:273-283.
29. Marionneau C., Couette B., Liu J., Li H., Mangoni M.E., Nargeot J., et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol (Lond) 2005, 562:223-234.
30. Leoni A.-L., Marionneau C., Demolombe S., Le Bouter S., Mangoni M.E., Escande D., et al. Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle. Physiol Genomics 2005, 24:4-12.
31. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
32. Glasscock E., Qian J., Yoo J.W., Noebels J.L. Masking epilepsy by combining two epilepsy genes. Nat Neurosci 2007, 10:1554-1558.
33. Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R., Smith E.A., Kramer P., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994, 8:136-140.
34. Liguori R., Avoni P., Baruzzi A., Di Stasi V., Montagna P. Familial continuous motor unit activity and epilepsy. Muscle Nerve 2001, 24:630-633.
35. Demos M.K., Macri V., Farrell K., Nelson T.N., Chapman K., Accili E., et al. A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction. Mov Disord 2009, 24:778-782.
36. Zuberi S.M., Eunson L.H., Spauschus A., De Silva R., Tolmie J., Wood N.W., et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999, 122(Pt 5):817-825.
37. Noda M., Ikeda T., Kayano T., Suzuki H., Takeshima H., Kurasaki M., et al. Existence of distinct sodium channel messenger RNAs in rat brain. Nature 1986, 320:188-192.
38. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007, 27:5903-5914.
39. + channel subtypes in central neurons. Neuron 1989, 3:695-704.
40. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9:1142-1149.
41. Whitaker W.R., Faull R.L., Waldvogel H.J., Plumpton C.J., Emson P.C., Clare J.J. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res 2001, 88:37-53.
42. Gong B., Rhodes K.J., Bekele-Arcuri Z., Trimmer J.S. Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J Comp Neurol 1999, 412:342-352.
43. Lorincz A., Nusser Z. Molecular identity of dendritic voltage-gated sodium channels. Science 2010, 328:906-909.
44. Lorincz A., Nusser Z. Cell-type-dependent molecular composition of the axon initial segment. J Neurosci 2008, 28:14329-14340.
45. Dhar Malhotra J., Chen C., Rivolta I., Abriel H., Malhotra R., Mattei L.N., et al. Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes. Circulation 2001, 103:1303-1310.
46. + channel isoform. Proc Natl Acad Sci U S A 1989, 86:8170-8174.
47. Maier S.K.G., Westenbroek R.E., McCormick K.A., Curtis R., Scheuer T., Catterall W.A. Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart. Circulation 2004, 109:1421-1427.
48. Maier S.K.G., Westenbroek R.E., Yamanushi T.T., Dobrzynski H., Boyett M.R., Catterall W.A., et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A 2003, 100:3507-3512.
49. Maier S.K.G., Westenbroek R.E., Schenkman K.A., Feigl E.O., Scheuer T., Catterall W.A. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci U S A 2002, 99:4073-4078.
50. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
51. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000, 24:343-345.
52. Meisler M.H., O'Brien J.E., Sharkey L.M. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol (Lond) 2010, 588:1841-1848.
53. Meisler M.H., Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005, 115:2010-2017.
54. Hindocha N., Nashef L., Elmslie F., Birch R., Zuberi S., Al-Chalabi A., et al. Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. Epilepsia 2008, 49:360-365.
55. Genton P., Velizarova R., Dravet C. Dravet syndrome: the long-term outcome. Epilepsia 2011, 52(Suppl. 2):44-49.
56. Le Gal F., Korff C.M., Monso-Hinard C., Mund M.T., Morris M., Malafosse A., et al. A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation. Epilepsia 2010, 51:1915-1918.
57. Delogu A.B.., Spinelli A., Battaglia D., Dravet C., De Nisco A., Saracino A., et al. Electrical and autonomic cardiac function in patients with Dravet syndrome. Epilepsia 2011, 52(Suppl. 2):55-58.
58. Ergul Y., Ekici B., Tatli B., Nisli K., Ozmen M. QT and P wave dispersion and heart rate variability in patients with Dravet syndrome. Acta Neurol Belg 2013, 113:161-166.
59. Martin M.S., Dutt K., Papale L.A., Dubé C.M., Dutton S.B., de Haan G., et al. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 2010, 285:9823-9834.
60. Cheah C.S., Yu F.H., Westenbroek R.E., Kalume F.K., Oakley J.C., Potter G.B., et al. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A 2012, 109:14646-14651.
61. Hu W., Tian C., Li T., Yang M., Hou H., Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat Neurosci 2009, 12:996-1002.
62. Burgess D.L., Kohrman D.C., Galt J., Plummer N.W., Jones J.M., Spear B., et al. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant "motor endplate disease". Nat Genet 1995, 10:461-465.
63. Royeck M., Horstmann M.-T., Remy S., Reitze M., Yaari Y., Beck H. Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons. J Neurophysiol 2008, 100:2361-2380.
64. Osorio N., Cathala L., Meisler M.H., Crest M., Magistretti J., Delmas P. Persistent Nav1.6 current at axon initial segments tunes spike timing of cerebellar granule cells. J Physiol (Lond) 2010, 588:651-670.
65. Liao Y., Deprez L., Maljevic S., Pitsch J., Claes L., Hristova D., et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain 2010, 133:1403-1414.
66. Krzemien D.M., Schaller K.L., Levinson S.R., Caldwell J.H. Immunolocalization of sodium channel isoform NaCh6 in the nervous system. J Comp Neurol 2000, 420:70-83.
67. Schaller K.L., Caldwell J.H. Developmental and regional expression of sodium channel isoform NaCh6 in the rat central nervous system. J Comp Neurol 2000, 420:84-97.
68. Caldwell J.H., Schaller K.L., Lasher R.S., Peles E., Levinson S.R. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci U S A 2000, 97:5616-5620.
69. Boiko T., Rasband M.N., Levinson S.R., Caldwell J.H., Mandel G., Trimmer J.S., et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001, 30:91-104.
70. Noujaim S.F., Kaur K., Milstein M., Jones J.M., Furspan P., Jiang D., et al. A null mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart. FASEB J 2012, 26:63-72.
71. Du Y., Huang X., Wang T., Han K., Zhang J., Xi Y., et al. Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflugers Arch 2007, 454:451-459.
72. Papale L.A., Beyer B., Jones J.M., Sharkey L.M., Tufik S., Epstein M., et al. Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice. Hum Mol Genet 2009, 18:1633-1641.
73. Sun W., Wagnon J.L., Mahaffey C.L., Briese M., Ule J., Frankel W.N. Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice. J Physiol (Lond) 2013, 591:241-255.
74. Veeramah K.R., O'Brien J.E., Meisler M.H., Cheng X., Dib-Hajj S.D., Waxman S.G., et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet 2012, 90:502-510.
75. Robinson R.B., Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 2003, 65:453-480.
76. Biel M., Wahl-Schott C., Michalakis S., Zong X. Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 2009, 89:847-885.
77. Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R., Siegelbaum S.A., et al. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 1998, 93:717-729.
78. Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 1998, 393:587-591.
79. Moosmang S., Biel M., Hofmann F., Ludwig A. Differential distribution of four hyperpolarization-activated cation channels in mouse brain. Biol Chem 1999, 380:975-980.
80. Santoro B., Chen S., Luthi A., Pavlidis P., Shumyatsky G.P., Tibbs G.R., et al. Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS. J Neurosci 2000, 20:5264-5275.
81. Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999, 85:e1-e6.
82. Ye B., Nerbonne J.M. Proteolytic processing of HCN2 and co-assembly with HCN4 in the generation of cardiac pacemaker channels. J Biol Chem 2009, 284:25553-25559.
83. Hoppe U.C., Beuckelmann D.J. Characterization of the hyperpolarization-activated inward current in isolated human atrial myocytes. Cardiovasc Res 1998, 38:788-801.
84. Robinson R.B., Yu H., Chang F., Cohen I.S. Developmental change in the voltage-dependence of the pacemaker current, if, in rat ventricle cells. Pflugers Arch 1997, 433:533-535.
85. Ludwig A., Budde T., Stieber J., Moosmang S., Wahl C., Holthoff K., et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J 2003, 22:216-224.
86. Chung W.K., Shin M., Jaramillo T.C., Leibel R.L., LeDuc C.A., Fischer S.G., et al. Absence epilepsy in apathetic, a spontaneous mutant mouse lacking the h channel subunit, HCN2. Neurobiol Dis 2009, 33:499-508.
87. DiFrancesco J.C., Barbuti A., Milanesi R., Coco S., Bucchi A., Bottelli G., et al. Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy. J Neurosci 2011, 31:17327-17337.
88. Tu E., Waterhouse L., Duflou J., Bagnall R.D., Semsarian C. Genetic analysis of hyperpolarization-activated cyclic nucleotide-gated cation channels in sudden unexpected death in epilepsy cases. Brain Pathol 2011, 21:692-698.
89. Heron S.E., Grinton B.E., Kivity S., Afawi Z., Zuberi S.M., Hughes J.N., et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012, 90:152-160.
90. Chen W.-J., Lin Y., Xiong Z.-Q., Wei W., Ni W., Tan G.-H., et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011, 43:1252-1255.
91. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
92. Lee H.-Y., Huang Y., Bruneau N., Roll P., Roberson E.D.O., Hermann M., et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012, 1:2-12.
93. Heron S.E., Dibbens L.M. Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy. J Med Genet 2013, 50:133-139.
94. Wu C., MacLeod I., Su A.I. BioGPS and MyGene.info: organizing online, gene-centric, information 2012, 41:D561-D565.
95. Labate A., Tarantino P., Palamara G., Gagliardi M., Cavalcanti F., Ferlazzo E., et al. Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP. Epilepsy Res 2013, 104:280-284.
96. Moss A.J., Kass R.S. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 2005, 115:2018-2024.
97. Lu J.T., Kass R.S. Recent progress in congenital long QT syndrome. Curr Opin Cardiol 2010, 25:216-221.
98. Sanguinetti M.C. HERG1 channelopathies. Pflugers Arch 2010, 460:265-276.
99. Keller D.I., Grenier J., Christé G., Dubouloz F., Osswald S., Brink M., et al. Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Can J Cardiol 2009, 25:455-462.
100. Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S., Atkinson D.L., et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996, 384:80-83.
101. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384:78-80.
102. Goldman A.M., Glasscock E., Yoo J., Chen T.T., Klassen T.L., Noebels J.L. Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med 2009, 1:2ra6.
103. McLean B.N., Wimalaratna S. Sudden death in epilepsy recorded in ambulatory EEG. J Neurol Neurosurg Psychiatry 2007, 78:1395-1397.
104. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
105. Sanguinetti M.C., Jiang C., Curran M.E., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
106. Warmke J.W., Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A 1994, 91:3438-3442.
107. Guasti L., Cilia E., Crociani O., Hofmann G., Polvani S., Becchetti A., et al. Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: evidence for coassembly of different subunits. J Comp Neurol 2005, 491:157-174.
108. Polvani S., Masi A., Pillozzi S., Gragnani L., Crociani O., Olivotto M., et al. Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3. Gene Expr Patterns 2003, 3:767-776.
109. Sacco T., Bruno A., Wanke E., Tempia F. Functional roles of an ERG current isolated in cerebellar Purkinje neurons. J Neurophysiol 2003, 90:1817-1828.
110. + channels regulate excitability and discharge dynamics of the medial vestibular nucleus neurones. J Physiol (Lond) 2008, 586:4877-4890.
111. + channels contribute to threshold excitability of mouse auditory brainstem neurons. J Physiol (Lond) 2009, 587:2487-2497.
112. Emmi A., Wenzel H.J., Schwartzkroin P.A., Taglialatela M., Castaldo P., Bianchi L., et al. Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J Neurosci 2000, 20:3915-3925.
113. Zamorano-León J.J., Yañez R., Jaime G., Rodriguez-Sierra P., Calatrava-Ledrado L., Alvarez-Granada R.R., et al. KCNH2 gene mutation: a potential link between epilepsy and long QT-2 syndrome. J Neurogenet 2012, 26:382-386.
114. Johnson J.N., Hofman N., Haglund C.M., Cascino G.D., Wilde A.A.M., Ackerman M.J. Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology 2009, 72:224-231.
115. Tu E., Bagnall R.D., Duflou J., Semsarian C. Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol 2011, 21:201-208.
116. Fodstad H., Swan H., Laitinen P., Piippo K., Paavonen K., Viitasalo M., et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 2004, 36(Suppl. 1):53-63.
117. Tester D.J., Ackerman M.J. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007, 49:240-246.
118. Kasbekar D.P., Nelson J.C., Hall L.M. Enhancer of seizure: a new genetic locus in Drosophila melanogaster defined by interactions with temperature-sensitive paralytic mutations. Genetics 1987, 116:423-431.
119. Gellens M.E., George A.L., Chen L.Q., Chahine M., Horn R., Barchi R.L., et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A 1992, 89:554-558.
120. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80:805-811.
121. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998, 392:293-296.
122. Khan I.A., Nair C.K. Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease. Ann Noninvasive Electrocardiol 2004, 9:280-289.
123. + current in the medial entorhinal cortex. Neuron 1993, 11:1037-1047.
124. Hartmann H.A., Colom L.V., Sutherland M.L., Noebels J.L. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nat Neurosci 1999, 2:593-595.
125. Wu L., Nishiyama K., Hollyfield J.G., Wang Q. Localization of Nav1.5 sodium channel protein in the mouse brain. Neuroreport 2002, 13:2547-2551.
126. Donahue L.M., Coates P.W., Lee V.H., Ippensen D.C., Arze S.E., Poduslo S.E. The cardiac sodium channel mRNA is expressed in the developing and adult rat and human brain. Brain Res 2000, 887:335-343.
127. Parisi P., Oliva A., Coll Vidal M., Partemi S., Campuzano O., Iglesias A., et al. Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation. Epilepsy Res 2013, 105:415-418.
128. Aurlien D., Leren T.P., Taubøll E., Gjerstad L. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure 2009, 18:158-160.
129. Albert C.M., Nam E.G., Rimm E.B., Jin H.W., Hajjar R.J., Hunter D.J., et al. Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation 2008, 117:16-23.
130. Schwartz P.J., Priori S.G., Dumaine R., Napolitano C., Antzelevitch C., Stramba-Badiale M., et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000, 343:262-267.
131. Vatta M., Dumaine R., Varghese G., Richard T.A., Shimizu W., Aihara N., et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002, 11:337-345.
132. Van den Berg M.P., Haaksma J., Veeger N.J.G.M., Wilde A.A.M. Diurnal variation of ventricular repolarization in a large family with LQT3-Brugada syndrome characterized by nocturnal sudden death. Heart Rhythm 2006, 3:290-295.
133. Schwartz P.J., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103:89-95.
134. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990, 265:13472-13483.
135. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003, 4:517-529.
136. Gaborit N., Le Bouter S., Szuts V., Varro A., Escande D., Nattel S., et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol (Lond) 2007, 582:675-693.
137. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103:196-200.
138. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001, 103:485-490.
139. Berridge M.J. Neuronal calcium signaling. Neuron 1998, 21:13-26.
140. Giannini G., Conti A., Mammarella S., Scrobogna M., Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol 1995, 128:893-904.
141. Hertle D.N., Yeckel M.F. Distribution of inositol-1,4,5-trisphosphate receptor isotypes and ryanodine receptor isotypes during maturation of the rat hippocampus. Neuroscience 2007, 150:625-638.
142. 2+ release channels in rat brain. J Neurosci 1993, 13:3051-3063.
143. Bruno A.M., Huang J.Y., Bennett D.A., Marr R.A., Hastings M.L., Stutzmann G.E. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2012, 1001:e1-e6.
144. 2+ signaling and susceptibility to apoptosis. Circ Res 2007, 100:874-883.
145. 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 2008, 118:2230-2245.
146. Johnson J.N., Tester D.J., Bass N.E., Ackerman M.J. Cardiac channel molecular autopsy for sudden unexpected death in epilepsy. J Child Neurol 2010, 25:916-921.
147. Kearney J.A. Advances in epilepsy genetics and genomics. Epilepsy Curr 2012, 12:143-146.
148. Scheffer I.E. Genetic testing in epilepsy: what should you be doing?. Epilepsy Curr 2011, 11:107-111.
149. Holth J.K., Bomben V.C., Reed J.G., Inoue T., Younkin L., Younkin S.G., et al. Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci 2013, 33:1651-1659.
150. Surges R., Thijs R.D., Tan H.L., Sander J.W. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol 2009, 5:492-504.